Call for papers - Continuous glucose monitoring in diabetes

Guest Editors

Giacomo Cappon, PhD, University of Padova, Italy
Jee Hee Yoo, MD, PhD, Chung-Ang University College of Medicine, South Korea
Yongwen Zhou, MD, PhD, Sun Yat-sen University, China

Submission Status: Open | Submission Deadline: 10 April 2026

BMC Endocrine Disorders is calling for submissions to our Collection, Continuous glucose monitoring in diabetes. This Collection seeks to gather comprehensive research on continuous glucose monitoring (CGM) in diabetes management. We welcome submissions that investigate advancements in wearable sensors, non-invasive monitoring techniques, and the impact of real-time glucose tracking on glycemic control. The goal is to illuminate innovative strategies and technologies that can enhance diabetes care and improve patient outcomes.

New Content Item This Collection supports and amplifies research related to SDG 3: Good Heath and Well-being.

Submit to Collection

Meet the Guest Editors

Back to top

Giacomo Cappon, PhD, University of Padova, Italy

Dr Giacomo Cappon is an Assistant Professor of Bioengineering at the Department of Information Engineering, University of Padova. He received his MSc and PhD from the same university, where he has been working on the development of data-driven tools to support the management of chronic metabolic conditions, with a focus on type 1 diabetes. His research interests include digital health, physiological modeling, and the use of machine learning to analyze and interpret data from wearable sensors, insulin delivery devices, and continuous glucose monitors. He is particularly involved in exploring digital twin approaches, artificial intelligence, and simulation tools to support clinical decision-making and therapy optimization.

Jee Hee Yoo, MD, PhD, Chung-Ang University College of Medicine, South Korea

Dr Jee Hee Yoo is an Assistant Professor in the Division of Endocrinology and Metabolism at Chung-Ang University College of Medicine, South Korea. She earned her PhD in medicine from Sungkyunkwan University and completed clinical fellowships in endocrinology at Asan Medical Center and Samsung Medical Center. Her research focuses on diabetes technology, including the implementation of continuous glucose monitoring (CGM) and structured education to optimize glycemic control in individuals with type 1 and type 2 diabetes. She is particularly interested in addressing the needs of older adults and populations who are unfamiliar with technology and may face unique challenges in adopting digital health tools. With the increasing clinical use of CGM, Dr Yoo has been investigating novel CGM-derived metrics that go beyond traditional HbA1c-based assessments. Her work explores the characteristics, clinical relevance, and predictive value of these metrics, particularly in relation to diabetes complications.

Yongwen Zhou, MD, PhD, Sun Yat-sen University, China

Dr Yongwen Zhou is a physician in the Department of Endocrinology and Metabolism at the Third Affiliated Hospital of Sun Yat-sen University, China. She specializes in the clinical care and research of type 1 diabetes across all age groups, including children, adolescents, and adults. Her research interests focus on the real-world application and effectiveness of diabetes technologies, with particular attention to their implementation and optimization among children and youth. She is also deeply committed to advancing health equity by promoting fair access to diabetes technologies in resource-limited and underserved regions, and strives to ensure that patients in disadvantaged and remote areas can benefit from the latest advances in diabetes management, aiming to improve health outcomes and quality of life for children and adolescents living with diabetes.

About the Collection

BMC Endocrine Disorders is calling for submissions to our Collection, Continuous glucose monitoring in diabetes.

Continuous glucose monitoring (CGM) has revolutionized diabetes management by offering a comprehensive picture of glycemic status, and providing real-time glucose data to support prompt and informed decisions. This Collection aims to explore the latest advancements in CGM technology, including the integration of wearable sensors, non-invasive methods, and enhanced sensor accuracy. As diabetes prevalence continues to rise globally, the need for effective, convenient, and easy-to-wear monitoring solutions that can improve glycemic control and overall health outcomes has never been more urgent.

The significance of CGM technology lies in its potential to transform diabetes care by allowing for proactive management rather than reactive measures. Recent innovations have led to more accurate sensors and user-friendly devices, empowering individuals with diabetes to achieve better blood glucose control. Additionally, CGM systems can facilitate personalized insulin therapy and enhance patient-provider communication. As we gather research for this Collection, it is vital to consider how these advances can be optimized to further improve quality of life for those living with diabetes.

With ongoing research and development, the future of CGM is promising. We may see the emergence of more sophisticated wearable technologies that not only track glucose levels but also integrate with artificial intelligence to predict fluctuations, recommend lifestyle changes, and optimize insulin delivery. Such innovations could lead to more personalized and effective diabetes management strategies, ultimately improving patient outcomes and reducing the burden of diabetes-related complications.

Topics that are welcome include, but are not limited to, the following:

Advances in wearable glucose monitoring technology
Integration of non-invasive sensors in diabetes management
Enhancing sensor accuracy for better glycemic control
Real-time glucose tracking and its impact on insulin therapy

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Continuous glucose monitoring in diabetes" from the dropdown menu.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.